DOSE DEPENDENT EFFECT OF INTRAVENOUS FENTANYL ADMINISTRATION ON TICAGRELOR ABSORPTION AND PLATELET INHIBITION IN PATIENTS RECEIVING PERCUTANEOUS CORONARY INTERVENTION: A SECONDARY-ANALYSIS OF THE PACIFY RANDOMIZED CLINICAL TRIAL

Platelet function was measured at 2 hours using VerifyNow (Platelet Reactivity Units, PRU) and light-transmission aggregometry (measuring ADP-induced platelet aggregation). The lower dose fentanyl group also appeared to have more pronounced platelet inhibition by PRUs, though these results were not...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2018-03, Vol.71 (11), p.A1362-A1362
Main Authors: McEvoy, John W., Goli, Rakesh R., Ibrahim, Khalil, Shah, Rohan, Kickler, Thomas S., Clarke, William A., Schulman, Steven
Format: Article
Language:English
Subjects:
Angioplasty
Clinical trials
Fentanyl
Intravenous administration
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page A1362
container_issue 11
container_start_page A1362
container_title Journal of the American College of Cardiology
container_volume 71
creator McEvoy, John W.
Goli, Rakesh R.
Ibrahim, Khalil
Shah, Rohan
Kickler, Thomas S.
Clarke, William A.
Schulman, Steven
description Platelet function was measured at 2 hours using VerifyNow (Platelet Reactivity Units, PRU) and light-transmission aggregometry (measuring ADP-induced platelet aggregation). The lower dose fentanyl group also appeared to have more pronounced platelet inhibition by PRUs, though these results were not significant (84 vs 119, p=0.11) In linear regression analyses, for every unit increase in procedural fentanyl dose, there was a 33 unit increase in PRU (p=0.03) and a 11% increase in ADP-induced platelet aggregation (p=0.01).
doi_str_mv 10.1016/S0735-1097(18)31903-X
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2014384199</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S073510971831903X</els_id><sourcerecordid>2014384199</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1569-a0f9cb5bc483adf85f7242f38428e12e0b734883781af3e347346ee726ce633b3</originalsourceid><addsrcrecordid>eNqFUc2K1DAALqLguPoIQsCLHqpJ05_Ui2TTdCbQTUqSWXa8hE4nhS66s7a7gu-7D7LpjHgVAiX5fssXRe8R_Iwgyr8YWOAsRrAsPiLyCaMS4vjmRbRCWUZinJXFy2j1j_I6ejPPtxDCnKByFT1VynBQ8ZbLiksLeF1zZoGqgZBW02su1daAOkBU7hpAqyshhQmIFUqCcKxgdK15ozSgl0bp9gRQWYG2oZY33AanjbgUp3chQRukwc4AzRkX10KuQcs124YAvmQxpZWkercU4DoUWIRfAQWGMyWrgMRU0mZnhFlq2g0PlkzUO6BDqroS33kFWBNqMtoAqwVt3kavhu7H7N_9_V5E25pbtokbtV5YcY-yvIw7OJT9Ptv3KcHdYSDZUCRpMmCSJsSjxMN9gVNCcEFQN2CP03DNvS-SvPc5xnt8EX04-95Px1-Pfn5wt8fH6S5EugSiNBihsgys7Mzqp-M8T35w99P4s5v-OATdMqg7DeqWtRwi7jSouwm6b2edD7_we_STm_vR3_X-ME6-f3CH4_gfh2c1xZdz</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2014384199</pqid></control><display><type>article</type><title>DOSE DEPENDENT EFFECT OF INTRAVENOUS FENTANYL ADMINISTRATION ON TICAGRELOR ABSORPTION AND PLATELET INHIBITION IN PATIENTS RECEIVING PERCUTANEOUS CORONARY INTERVENTION: A SECONDARY-ANALYSIS OF THE PACIFY RANDOMIZED CLINICAL TRIAL</title><source>BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS</source><creator>McEvoy, John W. ; Goli, Rakesh R. ; Ibrahim, Khalil ; Shah, Rohan ; Kickler, Thomas S. ; Clarke, William A. ; Schulman, Steven</creator><creatorcontrib>McEvoy, John W. ; Goli, Rakesh R. ; Ibrahim, Khalil ; Shah, Rohan ; Kickler, Thomas S. ; Clarke, William A. ; Schulman, Steven</creatorcontrib><description>Platelet function was measured at 2 hours using VerifyNow (Platelet Reactivity Units, PRU) and light-transmission aggregometry (measuring ADP-induced platelet aggregation). The lower dose fentanyl group also appeared to have more pronounced platelet inhibition by PRUs, though these results were not significant (84 vs 119, p=0.11) In linear regression analyses, for every unit increase in procedural fentanyl dose, there was a 33 unit increase in PRU (p=0.03) and a 11% increase in ADP-induced platelet aggregation (p=0.01).</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/S0735-1097(18)31903-X</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>Angioplasty ; Clinical trials ; Fentanyl ; Intravenous administration</subject><ispartof>Journal of the American College of Cardiology, 2018-03, Vol.71 (11), p.A1362-A1362</ispartof><rights>2018 American College of Cardiology Foundation</rights><rights>Copyright Elsevier Limited Mar 10, 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>McEvoy, John W.</creatorcontrib><creatorcontrib>Goli, Rakesh R.</creatorcontrib><creatorcontrib>Ibrahim, Khalil</creatorcontrib><creatorcontrib>Shah, Rohan</creatorcontrib><creatorcontrib>Kickler, Thomas S.</creatorcontrib><creatorcontrib>Clarke, William A.</creatorcontrib><creatorcontrib>Schulman, Steven</creatorcontrib><title>DOSE DEPENDENT EFFECT OF INTRAVENOUS FENTANYL ADMINISTRATION ON TICAGRELOR ABSORPTION AND PLATELET INHIBITION IN PATIENTS RECEIVING PERCUTANEOUS CORONARY INTERVENTION: A SECONDARY-ANALYSIS OF THE PACIFY RANDOMIZED CLINICAL TRIAL</title><title>Journal of the American College of Cardiology</title><description>Platelet function was measured at 2 hours using VerifyNow (Platelet Reactivity Units, PRU) and light-transmission aggregometry (measuring ADP-induced platelet aggregation). The lower dose fentanyl group also appeared to have more pronounced platelet inhibition by PRUs, though these results were not significant (84 vs 119, p=0.11) In linear regression analyses, for every unit increase in procedural fentanyl dose, there was a 33 unit increase in PRU (p=0.03) and a 11% increase in ADP-induced platelet aggregation (p=0.01).</description><subject>Angioplasty</subject><subject>Clinical trials</subject><subject>Fentanyl</subject><subject>Intravenous administration</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNqFUc2K1DAALqLguPoIQsCLHqpJ05_Ui2TTdCbQTUqSWXa8hE4nhS66s7a7gu-7D7LpjHgVAiX5fssXRe8R_Iwgyr8YWOAsRrAsPiLyCaMS4vjmRbRCWUZinJXFy2j1j_I6ejPPtxDCnKByFT1VynBQ8ZbLiksLeF1zZoGqgZBW02su1daAOkBU7hpAqyshhQmIFUqCcKxgdK15ozSgl0bp9gRQWYG2oZY33AanjbgUp3chQRukwc4AzRkX10KuQcs124YAvmQxpZWkercU4DoUWIRfAQWGMyWrgMRU0mZnhFlq2g0PlkzUO6BDqroS33kFWBNqMtoAqwVt3kavhu7H7N_9_V5E25pbtokbtV5YcY-yvIw7OJT9Ptv3KcHdYSDZUCRpMmCSJsSjxMN9gVNCcEFQN2CP03DNvS-SvPc5xnt8EX04-95Px1-Pfn5wt8fH6S5EugSiNBihsgys7Mzqp-M8T35w99P4s5v-OATdMqg7DeqWtRwi7jSouwm6b2edD7_we_STm_vR3_X-ME6-f3CH4_gfh2c1xZdz</recordid><startdate>20180310</startdate><enddate>20180310</enddate><creator>McEvoy, John W.</creator><creator>Goli, Rakesh R.</creator><creator>Ibrahim, Khalil</creator><creator>Shah, Rohan</creator><creator>Kickler, Thomas S.</creator><creator>Clarke, William A.</creator><creator>Schulman, Steven</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20180310</creationdate><title>DOSE DEPENDENT EFFECT OF INTRAVENOUS FENTANYL ADMINISTRATION ON TICAGRELOR ABSORPTION AND PLATELET INHIBITION IN PATIENTS RECEIVING PERCUTANEOUS CORONARY INTERVENTION: A SECONDARY-ANALYSIS OF THE PACIFY RANDOMIZED CLINICAL TRIAL</title><author>McEvoy, John W. ; Goli, Rakesh R. ; Ibrahim, Khalil ; Shah, Rohan ; Kickler, Thomas S. ; Clarke, William A. ; Schulman, Steven</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1569-a0f9cb5bc483adf85f7242f38428e12e0b734883781af3e347346ee726ce633b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Angioplasty</topic><topic>Clinical trials</topic><topic>Fentanyl</topic><topic>Intravenous administration</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McEvoy, John W.</creatorcontrib><creatorcontrib>Goli, Rakesh R.</creatorcontrib><creatorcontrib>Ibrahim, Khalil</creatorcontrib><creatorcontrib>Shah, Rohan</creatorcontrib><creatorcontrib>Kickler, Thomas S.</creatorcontrib><creatorcontrib>Clarke, William A.</creatorcontrib><creatorcontrib>Schulman, Steven</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McEvoy, John W.</au><au>Goli, Rakesh R.</au><au>Ibrahim, Khalil</au><au>Shah, Rohan</au><au>Kickler, Thomas S.</au><au>Clarke, William A.</au><au>Schulman, Steven</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>DOSE DEPENDENT EFFECT OF INTRAVENOUS FENTANYL ADMINISTRATION ON TICAGRELOR ABSORPTION AND PLATELET INHIBITION IN PATIENTS RECEIVING PERCUTANEOUS CORONARY INTERVENTION: A SECONDARY-ANALYSIS OF THE PACIFY RANDOMIZED CLINICAL TRIAL</atitle><jtitle>Journal of the American College of Cardiology</jtitle><date>2018-03-10</date><risdate>2018</risdate><volume>71</volume><issue>11</issue><spage>A1362</spage><epage>A1362</epage><pages>A1362-A1362</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>Platelet function was measured at 2 hours using VerifyNow (Platelet Reactivity Units, PRU) and light-transmission aggregometry (measuring ADP-induced platelet aggregation). The lower dose fentanyl group also appeared to have more pronounced platelet inhibition by PRUs, though these results were not significant (84 vs 119, p=0.11) In linear regression analyses, for every unit increase in procedural fentanyl dose, there was a 33 unit increase in PRU (p=0.03) and a 11% increase in ADP-induced platelet aggregation (p=0.01).</abstract><cop>New York</cop><pub>Elsevier Inc</pub><doi>10.1016/S0735-1097(18)31903-X</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0735-1097
ispartof Journal of the American College of Cardiology, 2018-03, Vol.71 (11), p.A1362-A1362
issn 0735-1097
1558-3597
language eng
recordid cdi_proquest_journals_2014384199
source BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS
subjects Angioplasty
Clinical trials
Fentanyl
Intravenous administration
title DOSE DEPENDENT EFFECT OF INTRAVENOUS FENTANYL ADMINISTRATION ON TICAGRELOR ABSORPTION AND PLATELET INHIBITION IN PATIENTS RECEIVING PERCUTANEOUS CORONARY INTERVENTION: A SECONDARY-ANALYSIS OF THE PACIFY RANDOMIZED CLINICAL TRIAL
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T20%3A26%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=DOSE%20DEPENDENT%20EFFECT%20OF%20INTRAVENOUS%20FENTANYL%20ADMINISTRATION%20ON%20TICAGRELOR%20ABSORPTION%20AND%20PLATELET%20INHIBITION%20IN%20PATIENTS%20RECEIVING%20PERCUTANEOUS%20CORONARY%20INTERVENTION:%20A%20SECONDARY-ANALYSIS%20OF%20THE%20PACIFY%20RANDOMIZED%20CLINICAL%20TRIAL&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=McEvoy,%20John%20W.&rft.date=2018-03-10&rft.volume=71&rft.issue=11&rft.spage=A1362&rft.epage=A1362&rft.pages=A1362-A1362&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/S0735-1097(18)31903-X&rft_dat=%3Cproquest_cross%3E2014384199%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1569-a0f9cb5bc483adf85f7242f38428e12e0b734883781af3e347346ee726ce633b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2014384199&rft_id=info:pmid/&rfr_iscdi=true